You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 51 No. 3, March 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Subacute Inflammatory Demyelinating Polyneuropathy: Not a New Concept-Reply

Richard Hughes, MD, FRCP
Department of Neurology United Medical and Dental Schools Guy's Hospital London, United Kingdom SEI 9RT

Arch Neurol. 1994;51(3):235-236.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

in reply

I am pleased to acknowledge that Oh discussed the concept of an intermediate form of neuropathy between Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy in 1978 in the light of concepts then current in an article that we would have been pleased to quote if we had been aware of its existence. However, I find Oh's response confusing, since he appears to equate subacute demyelinating neuropathy with CIDP in the first sentence of his penultimate paragraph, and the modern definition of CIDP would classify nine of his 10 patients as having CIDP and not SIDP (subacute idiopathic demyelinating polyradiculopathy). Since we now have definitions of Guillain-Barré syndrome reaching its nadir within 4 weeks and CIDP reaching its nadir after 2 months (8 weeks would be better) from international committees, I adhere to the view that only the intermediate group should be considered to have SIDP. If patients with . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.